Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non–small-cell lung cancer patients

2019 ◽  
Vol 117 ◽  
pp. 107-115 ◽  
Author(s):  
Zong-Han Yao ◽  
Wei-Yu Liao ◽  
Chao-Chi Ho ◽  
Kuan-Yu Chen ◽  
Jin-Yuan Shih ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Epidermal Growth Factor Receptor ◽  
Receptor Tyrosine Kinase ◽  
Kinase Inhibitor ◽  
Growth Factor Receptor ◽  
Small Cell ◽  
Small Cell Lung ◽  
Lung Cancer Patients ◽  
Epidermal Growth ◽  
Inhibitor Treatment

scholarly journals Rebiopsy of non-small cell lung cancer patients with acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitor

Cancer ◽  
2013 ◽  
Vol 119 (24) ◽  
pp. 4325-4332 ◽  
Author(s):  
Akito Hata ◽  
Nobuyuki Katakami ◽  
Hiroshige Yoshioka ◽  
Jumpei Takeshita ◽  
Kosuke Tanaka ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Epidermal Growth Factor Receptor ◽  
Receptor Tyrosine Kinase ◽  
Kinase Inhibitor ◽  
Acquired Resistance ◽  
Growth Factor Receptor ◽  
Small Cell ◽  
Small Cell Lung ◽  
Lung Cancer Patients ◽  
Epidermal Growth
Sign in / Sign up

Export Citation Format

Share Document